Response to ibrutinib varies by DLBCL subtypeJuly 21, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Polyphenols may enhance doxorubicin treatmentJuly 17, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
YA cancer survivors hospitalized more oftenJuly 15, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Prenatal test results linked to cancer in mothersJuly 15, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
ASCO updates guideline on CSFsJuly 14, 2015AnemiaLymphoma & Plasma Cell DisordersPediatricsTransplantation
Adopting may be more difficult for cancer survivorsJuly 13, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology Nursing
Ibrutinib approved to treat WM in EUJuly 11, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Older cancer patients under-utilize advanced care planningJuly 10, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
AYAs with cancer receive aggressive EOL careJuly 10, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Early progression predicts overall survival in FLJuly 9, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Novel mAb targeting CD70 shows activity in TCLJuly 8, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
NICE wants more info on PI3Kδ inhibitorJuly 8, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Novel SYK inhibitor shows ‘good early evidence’ of activityJuly 5, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
